Earnings Feed
Start Free
Home/Filings/4/0001140361-12-017926
4//SEC Filing

Hochberg Abraham 4

Accession 0001140361-12-017926

CIK 0001451980other
View on SEC.govCompany Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 6:12 PM ET

Size

7.9 KB

Accession

0001140361-12-017926

Insider Transaction Report

Form 4
Period: 2011-09-27
BIOCANCELL THERAPEUTICS INC.BICL.TA
Hochberg Abraham
DirectorChief Scientist10% Owner
Transactions
  • Award

    Employee Options

    2011-09-27+60,000→ 180,000 total
    Exp: 2021-09-27→ Common Stock (60,000 underlying)
  • Award

    Employee Options

    2012-02-12+300,000→ 480,000 total
    Exp: 2022-02-12→ Common Stock (300,000 underlying)
Footnotes (4)
  • [F1]The exercise price is 2.85 NIS per share.
  • [F2]3,750 options shall vest and be exercisable at the end of each calendar quarter, from June 30, 2010 until all options are vested or until vesting is terminated in accordance with the terms of the options.
  • [F3]The exercise price is 1.583 NIS per share.
  • [F4]18,750 options shall vest and be exercisable at the end of each calendar quarter, from December 31, 2011 until all options are vested or until vesting is terminated in accordance with the terms of the options.

Documents

1 file

Issuer

BIOCANCELL THERAPEUTICS INC.

CIK 0001451980

→
Entity typeother

Related Parties

1
  • filerCIK 0001466926

Filing Metadata

Form type
4
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 6:12 PM ET
Size
7.9 KB
View on SEC.gov